SCHEMBL13634359

SCHEMBL13634359

CCCNC(=O)c1cc(C)ccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
THRB P10828 1/20 0.49
RECQL P46063 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALDH1A1 P00352 4/20 0.48
HPGD P15428 4/20 0.48
HSD17B10 Q99714 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPK1 P28482 2/20 0.48
TP53 P04637 1/20 0.48
KDM4E B2RXH2 3/20 0.47
HTT P42858 3/20 0.47
GABRG2 P18507 3/20 0.46
GABRB3 P28472 3/20 0.46
GABRA2 P47869 3/20 0.46
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13753816 0.87 HPGD (0.49) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPK1
SCHEMBL8323157 0.84 HPGD (0.56) POLBALDH1A1HPGDHSD17B10SMN1; SMN2
SCHEMBL7104333 0.83 L3MBTL1 (0.48) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL7813262 0.83 RECQL (0.68) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL18645554 0.82 NAAA (0.57) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL28456551 0.81 L3MBTL1 (0.49) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL12121132 0.81 POLB (0.53) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL13753858 0.80 POLB (0.59) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL7005423 0.79 ALDH1A1 (0.46) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPK1
SCHEMBL29016441 0.79 MAPT (0.57) THRBTDP1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017161119-A1 SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, INC. (US) 2017-09-21 WO disclosed
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed